| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/03/2011 | CN101041824B Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 08/03/2011 | CN101027396B Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof |
| 08/03/2011 | CN101024835B Ammonia transporter gene and use thereof |
| 08/02/2011 | US7991601 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 08/02/2011 | US7989686 Maize variety PHV7Y |
| 08/02/2011 | US7989685 Maize variety PHNAR |
| 08/02/2011 | US7989684 Maize variety PHW3G |
| 08/02/2011 | US7989681 Soybean cultivar 04KL023911 |
| 08/02/2011 | US7989680 Soybean cultivar 7631014 |
| 08/02/2011 | US7989679 Methods and compositions for improved enzyme activity in transgenic plants |
| 08/02/2011 | US7989678 Disarmed agrobacterium strains, Ri-plasmids, and methods of transformation based thereon |
| 08/02/2011 | US7989677 Nucleic acids and proteins associated with sucrose accumulation in coffee |
| 08/02/2011 | US7989676 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 08/02/2011 | US7989614 Isolation of nucleic acid |
| 08/02/2011 | US7989613 isolated polyribonucleotide is used to kill Class B metallo- beta -lactamase producing bacteria; enzyme inhibitor has higher affinity and specificity for binding; with penicillin or cephalosporin; new biodrug for treating bacterial infections |
| 08/02/2011 | US7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 08/02/2011 | US7989611 Expression control sequence |
| 08/02/2011 | US7989610 Protein, a gene encoding therefor and a method of using the same |
| 08/02/2011 | US7989609 Nucleic acid sequences encoding invertase proteins |
| 08/02/2011 | US7989608 Immunomodulatory agents and methods of use |
| 08/02/2011 | US7989607 Corn event TC1507 and methods for detection thereof |
| 08/02/2011 | US7989606 Phosphatase inhibitor protein-1 as a regulator of cardiac function |
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989594 Modified antibody fab fragments |
| 08/02/2011 | US7989591 Protein lattice |
| 08/02/2011 | US7989584 AKT nucleic acids, polypeptides, and uses thereof |
| 08/02/2011 | US7989429 LNA antagonists targeting the androgen receptor |
| 08/02/2011 | US7989428 Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989218 Protein fragment complementation assays for the detection of biological or drug interactions |
| 08/02/2011 | US7989210 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 08/02/2011 | US7989206 High expression Zymomonas promoters |
| 08/02/2011 | US7989202 Plant centromere compositions |
| 08/02/2011 | US7989201 Ret finger protein 2 (RFP2) promoter |
| 08/02/2011 | US7989193 Compositions and methods for producing gamma-carboxylated proteins |
| 08/02/2011 | US7989191 Mutant 6-phosphogluconate dehydrogenase |
| 08/02/2011 | US7989189 Mutant GTP cyclohydrolase II enzymes |
| 08/02/2011 | US7989187 Microorganisms and processes for enhanced production of pantothenate |
| 08/02/2011 | US7989183 Soluble fusion proteins comprising heterologous polypeptides |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989181 Methods and compositions for producing recombinant proteins using a gene for TRNA |
| 08/02/2011 | US7989166 Circle probes and their use in the identification of biomolecules |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/02/2011 | US7988972 Immunoreactive peptides from Epstein-Barr virus |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages |
| 08/02/2011 | CA2566776C Method for ameliorating an inflammatory skin condition |
| 08/02/2011 | CA2505067C Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/02/2011 | CA2486678C Non-viral gene delivery system |
| 08/02/2011 | CA2484604C .delta. 4,5 glycuronidase and uses thereof |
| 08/02/2011 | CA2484507C Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2450318C Improved methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2445864C A hot start amplification process using pyrophosphatase enzyme |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2441983C Substrates, preparation and use |
| 08/02/2011 | CA2425349C Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 08/02/2011 | CA2424253C Treatment of transgenic corn seeds with clothianidin |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2407309C Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 08/02/2011 | CA2395391C Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/02/2011 | CA2381184C Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 08/02/2011 | CA2370103C Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/02/2011 | CA2356696C Statistical combining of cell expression profiles |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2332655C Scce modified transgenic mammals and their use as models of human diseases |
| 08/02/2011 | CA2330829C Methods for treating a neurological disease by determining bche genotype |
| 08/02/2011 | CA2329683C Iga nephropathy-related dna |
| 08/02/2011 | CA2325052C Nucleic acid detection method |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2321169C Modified enzymes and their use for peptide synthesis |
| 08/02/2011 | CA2320220C Isolated dna or gene responsible for parkinson's disease |
| 08/02/2011 | CA2307640C Multiply-substituted protease variants |
| 08/02/2011 | CA2282300C Recombinant pox virus for immunization against muc1 tumor-associated antigen |
| 08/02/2011 | CA2265498C Staphylococcus aureus antigen |
| 08/02/2011 | CA2219275C Therapeutic agent and treatment for canine intractable dermatitis |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 08/02/2011 | CA1341619C Recombinant inhibin |
| 07/29/2011 | WO2010085694A2 Watercraft lift system |
| 07/28/2011 | WO2011091419A2 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery |
| 07/28/2011 | WO2011091396A1 Compositions and methods for inhibiting expression of mylip/idol gene |
| 07/28/2011 | WO2011091390A2 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1 |
| 07/28/2011 | WO2011091376A2 Immunogenic influenza composition |
| 07/28/2011 | WO2011091370A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 07/28/2011 | WO2011091328A2 Improved methods and compositions for determining the pathogenic status of infectious agents |
| 07/28/2011 | WO2011091324A2 Methods of generating zinc finger nucleases having altered activity |
| 07/28/2011 | WO2011091317A2 Engineered landing pads for gene targeting in plants |
| 07/28/2011 | WO2011091311A2 Excision of transgenes in genetically modified organisms |
| 07/28/2011 | WO2011091237A1 Consumable analytical plasticware comprising high-solubility plastics |
| 07/28/2011 | WO2011091106A2 Compositions and methods for gene signature - based chemical screening |
| 07/28/2011 | WO2011090985A2 Generation of asporogenous solventogenic clostridia |
| 07/28/2011 | WO2011090875A2 Primers, sequences and recombinant probes for identification of mycobacterium species |
| 07/28/2011 | WO2011090752A1 Male and female sterility lines used to make hybrids in genetically modified plants |
| 07/28/2011 | WO2011090741A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63 |
| 07/28/2011 | WO2011090740A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| 07/28/2011 | WO2011090731A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
| 07/28/2011 | WO2011090730A1 Recombinant thraustochytrids that grow on xylose, and compositions, methods of making, and uses thereof |